FinTrust Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-285	Closed	-$18K	–	1084
2019 Q3	$18K	Buy	285 +45	+19%	+$2.84K	0.01%	651
2019 Q2	$17K	Sell	240 -300	-56%	-$21.3K	0.01%	634
2019 Q1	$43K	Buy	540 +211	+64%	+$16.8K	0.02%	416
2018 Q4	$28K	Buy	+329	New	+$28K	0.01%	499